BioSpace News Archive

Brand Institute is proud to announce having worked with Myovant Sciences in developing the brand name ORGOVYX®, for an oral medication used to treat adult patients with advanced hormone-sensitive prostate cancer.

BioStem Technologies ® (OTC: BSEM), a leading, innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies will be hosted on Benzinga’s All Access show, which airs on Benzinga TV and Benzinga’s YouTube channel on June 17 2022, at 10:20 AM EST.

Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), announced today that the company is postponing the start of the live-streamed R&D event on June 20 until 14.00 CEST.

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a revenue-generating biotechnology company researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD) is pleased to announce that the company’s CEO Anthony Tennyson will be presenting at two investor conferences this June.

Children’s Mercy Kansas City will head into its new fiscal year July 1 with a full head of steam after S&P Global Ratings raised the hospital system’s long-term credit rating, citing its financial strength, performance and operating results.

The latest market analysis report published by Reports and Data, titled ‘Global Breathing Circuits Market – Forecast to 2028,’ thoroughly examines the Breathing Circuits industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Acute Repetitive Seizures Market – Forecast to 2028,’ thoroughly examines the Acute Repetitive Seizures industry to provide essential data & information for the targeted readers.

The global HLA typing for transplant market size is expected to reach USD 1,206.02 Million by 2028 at a CAGR of 7.0%, according to the latest report by Reports and Data

The global eClinical Solutions market size is expected to reach USD 15.98 Billion by 2028, registering a CAGR of 13.9% over the forecast period, according to the current analysis of Reports and Data.

The latest market analysis report published by Reports and Data, titled ‘Global In-Vitro Diagnostics (IVD) Quality Control Market – Forecast to 2028,’ thoroughly examines the In-Vitro Diagnostics (IVD) Quality Control industry to provide essential data & information for the targeted readers.